Model-based estimates of tumor growth inhibition (TGI) metrics to predict for overall survival (OS) in first-line non-small cell lung cancer (NSCLC).
Laurent Claret
Employment or Leadership Position - Pharsight
Pierre Mancini
Employment or Leadership Position - Sanofi
Stock Ownership - Sanofi
Bernard Sebastien
Employment or Leadership Position - Sanofi
Stock Ownership - Sanofi
Christine Veyrat-Follet
Employment or Leadership Position - Sanofi
Stock Ownership - Sanofi
Rene Bruno
Employment or Leadership Position - Pharsight